NO175870C - Replikerbar ekspresjonsvektor og fremgangsmåte for fremstilling av et biologisk aktivt heterologt polypeptid - Google Patents

Replikerbar ekspresjonsvektor og fremgangsmåte for fremstilling av et biologisk aktivt heterologt polypeptid

Info

Publication number
NO175870C
NO175870C NO863806A NO863806A NO175870C NO 175870 C NO175870 C NO 175870C NO 863806 A NO863806 A NO 863806A NO 863806 A NO863806 A NO 863806A NO 175870 C NO175870 C NO 175870C
Authority
NO
Norway
Prior art keywords
biologically active
producing
expression vector
heterologous polypeptide
replicable expression
Prior art date
Application number
NO863806A
Other languages
English (en)
Norwegian (no)
Other versions
NO863806D0 (no
NO175870B (cg-RX-API-DMAC7.html
NO863806L (no
Inventor
Jiuni Lai
Jar-How Lee
Yun-Long Lin
Dan Ray
Gary Wilcox
Original Assignee
Xoma Corp
Int Genetic Eng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp, Int Genetic Eng filed Critical Xoma Corp
Publication of NO863806D0 publication Critical patent/NO863806D0/no
Publication of NO863806L publication Critical patent/NO863806L/no
Publication of NO175870B publication Critical patent/NO175870B/no
Publication of NO175870C publication Critical patent/NO175870C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO863806A 1985-01-28 1986-09-24 Replikerbar ekspresjonsvektor og fremgangsmåte for fremstilling av et biologisk aktivt heterologt polypeptid NO175870C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69530985A 1985-01-28 1985-01-28
US79747285A 1985-11-13 1985-11-13
PCT/US1986/000131 WO1986004356A1 (en) 1985-01-28 1986-01-24 AraB PROMOTERS AND METHOD OF PRODUCING POLYPEPTIDES, INCLUDINN CECROPINS, BY MICROBIOLOGICAL TECHNIQUES

Publications (4)

Publication Number Publication Date
NO863806D0 NO863806D0 (no) 1986-09-24
NO863806L NO863806L (no) 1986-11-19
NO175870B NO175870B (cg-RX-API-DMAC7.html) 1994-09-12
NO175870C true NO175870C (no) 1994-12-21

Family

ID=27105550

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863806A NO175870C (no) 1985-01-28 1986-09-24 Replikerbar ekspresjonsvektor og fremgangsmåte for fremstilling av et biologisk aktivt heterologt polypeptid

Country Status (8)

Country Link
EP (2) EP0460709B1 (cg-RX-API-DMAC7.html)
JP (2) JPH082308B2 (cg-RX-API-DMAC7.html)
KR (1) KR870700095A (cg-RX-API-DMAC7.html)
AT (2) ATE101203T1 (cg-RX-API-DMAC7.html)
DE (2) DE3689598T2 (cg-RX-API-DMAC7.html)
FI (1) FI94774C (cg-RX-API-DMAC7.html)
NO (1) NO175870C (cg-RX-API-DMAC7.html)
WO (1) WO1986004356A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028530A (en) * 1985-01-28 1991-07-02 Xoma Corporation AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
US5166321A (en) * 1985-01-28 1992-11-24 International Genetic Engineering, Inc. Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria
US5597945A (en) * 1986-07-25 1997-01-28 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Plants genetically enhanced for disease resistance
ATE123528T1 (de) * 1986-07-25 1995-06-15 Univ Louisiana State Verfahren zum verleihen bei pflanzen eines widerstands gegen krankheiten und pest sowie neue gene in pflanzen die hierfür kodieren.
DE3716957A1 (de) * 1987-05-20 1988-12-01 Boehringer Mannheim Gmbh Expressionsvektor zur regulierbaren expression von fremdgenen in prokaryonten
US5861478A (en) 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
DE3854476T2 (de) * 1987-07-06 1996-04-04 Univ Louisiana State Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden.
CA1327311C (en) * 1987-07-06 1994-03-01 Jesse M. Jaynes Therapeutic antimicrobial polypeptides, their use and methods for preparation
EP0326419A3 (en) * 1988-01-27 1991-09-25 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF AGRICULTURE Vaccines for the protection of animals against hypodermosis
US5631007A (en) * 1990-03-12 1997-05-20 Ciba-Geigy Corporation Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes
PH30997A (en) * 1990-03-12 1997-12-23 Ciba Geigy Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
IL114697A0 (en) * 1994-07-22 1995-11-27 Demeter Biotech Ltd Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
US5589364A (en) * 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
WO1998011231A1 (en) * 1996-09-10 1998-03-19 The Rockefeller University Highly regulable promoter for heterologous gene expression
EP1259548A1 (en) 2000-02-24 2002-11-27 Eidgenössische Technische Hochschule Zürich Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
US20080206817A1 (en) 2004-12-07 2008-08-28 Johann Brass Rhamnose Promoter Expression System
EP2934532B1 (en) 2012-12-20 2019-10-23 Purdue Research Foundation Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
CA3019835A1 (en) 2016-04-08 2017-10-12 Purdue Research Foundation Methods and compositions for car t cell therapy
AU2018219226B2 (en) 2017-02-07 2024-12-19 Seattle Children's Hospital (dba Seattle Children's Research Institute) Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
CN110582288B (zh) 2017-02-28 2024-09-20 恩多塞特公司 用于car t细胞疗法的组合物和方法
WO2019144095A1 (en) 2018-01-22 2019-07-25 Seattle Children's Hospital (dba Seattle Children's Research Institute) Methods of use for car t cells
AU2019218729B2 (en) 2018-02-06 2025-12-04 Seattle Children's Hospital (dba Seattle Children's Research Institute) Fluorescein-specific CARs exhibiting optimal T cell function against FL-PLE labelled tumors
JP7568224B2 (ja) 2018-02-23 2024-10-16 エンドサイト・インコーポレイテッド Car t細胞療法のための配列決定法
IL295063A (en) 2020-02-04 2022-09-01 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Chimeric antigen receptors (car) against dinitrophenol
CN112575047B (zh) * 2020-12-29 2024-06-21 中农颖泰林州生物科园有限公司 一种提高饲料用的抗菌肽天蚕素收率的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4335104A (en) * 1978-08-16 1982-06-15 United Chemical Corporation Anhydrous multi-purpose moisturizing composition
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4520016A (en) * 1980-06-17 1985-05-28 Kabigen Ab Bacteriolytic proteins
US4355104A (en) 1980-06-17 1982-10-19 Kabigen Ab Bacteriolytic proteins
IL68561A (en) 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
JPS61501186A (ja) * 1983-10-11 1986-06-19 インターナシヨナル ジネテイツク エンジニアリング インコーポレイテツド タウマチン(Thaumatin)遺伝子の作製と発現

Also Published As

Publication number Publication date
FI863891A0 (fi) 1986-09-26
EP0211047A1 (en) 1987-02-25
DE3689598D1 (de) 1994-03-17
JPS62501538A (ja) 1987-06-25
EP0460709B1 (en) 1997-05-21
ATE101203T1 (de) 1994-02-15
NO863806D0 (no) 1986-09-24
FI863891L (fi) 1986-09-26
JPH0829112B2 (ja) 1996-03-27
EP0211047B1 (en) 1994-02-02
EP0460709A1 (en) 1991-12-11
DE3650625T2 (de) 1997-10-02
JPH082308B2 (ja) 1996-01-17
FI94774B (fi) 1995-07-14
NO175870B (cg-RX-API-DMAC7.html) 1994-09-12
ATE153377T1 (de) 1997-06-15
DE3689598T2 (de) 1994-06-30
WO1986004356A1 (en) 1986-07-31
NO863806L (no) 1986-11-19
EP0211047A4 (en) 1989-04-24
KR870700095A (ko) 1987-02-28
DE3650625D1 (de) 1997-06-26
FI94774C (fi) 1995-10-25
JPH0767684A (ja) 1995-03-14

Similar Documents

Publication Publication Date Title
NO863806D0 (no) Arab promotorer og fremgangsmaate for fremstilling av polypeptider inkludert cecropiner, ved mikrobiologiske teknikker.
NO932423L (no) Ekspresjon av rekombinante proteiner i attenuerte bakterier
DE3584053D1 (de) Gentechnologisches verfahren zur herstellung von hirudinen und mittel zur durchfuehrung dieses verfahrens.
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
SE8101005L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos humant interferon, dna och plasmider, som koderar for denna sekvens, mikroorganismer, som innehaller dessa genetiska informationer och forfaran...
EP0192741A4 (en) TOXIN SEGMENT OF THE -i CRYSTAL PROTEIN GENE (BACILLUS THURINGIENSIS).
DE69531200D1 (de) Rekombinante proteine des filamentoesen haemaglutinins von bordetella,im besonderen bordetella pertusis, herstellungsverfahren und ihre verwendung zur herstellung von fremdproteinen oder vakzinen
ATE290087T1 (de) Neue signalsequenzen
DK192189D0 (da) Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid
EP0317641A4 (en) Fused protein containing lymphotoxin
SE8101004L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos humant interferon, dna och plasmider, som koderar for denna sekvens, mikroorganismer, som innehaller dessa genetiska informationer och forfarande
ATE291629T1 (de) Expressionssystem für die sekretion von bioaktivem, menschlichem granulozyt-makrophagem koloniestimulierungsfaktor (gm-csf) und anderen heterologen proteinen aus streptomyces
DK454988D0 (da) Ekspressionsvektorer
ATE154392T1 (de) Kalzium-geregelter promotor
FI925674A0 (fi) Ny vektor foer framstaellning av biologiskt viktiga peptider